STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.

Cancer Epidemiol

Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, China. Electronic address:

Published: April 2014

Background: It has been suggested that the serine/threonine kinase 15 (STK15) T91A rs2273535 polymorphism is associated with susceptibility to cancer. However, the results are conflicting. We performed this meta-analysis to derive a more precise estimation of the relationship.

Methods: PubMed was searched to select studies. Case-control studies containing available genotype frequencies of the STK15 rs2273535 polymorphism were chosen, and the odds ratio (OR) with its 95% confidence interval (CI) was utilized to assess the strength of association.

Results: 52 studies - including 34,057 cases and 40,839 controls - were identified. A significant effect of the STK15 rs2273535 polymorphism on cancer risk was found (AA vs. TT: OR=1.13, 95%CI=1.01-1.26, Pheterogeneity<0.001; AA vs.

Ta/tt: OR=1.12, 95%CI=1.02-1.22, Pheterogeneity<0.001; TA/AA vs. TT: OR=1.06, 95%CI=1.01-1.12, Pheterogeneity<0.001). Stratified analysis by cancer type revealed that the STK rs2273535 polymorphism may contribute to the risk of breast cancer (AA vs. TT: OR=1.21, 95%CI=1.01-1.44, Pheterogeneity=0.002), colorectal cancer (AA vs.

Ta/tt: OR=1.24, 95%CI=1.05-1.47, Pheterogeneity=0.124), and esophageal cancer (AA vs.

Ta/tt: OR=1.19, 95%CI=1.02-1.39, Pheterogeneity=0.148). Further subgroup analysis by ethnicity indicated that there was a statistically increased cancer risk in Asians (AA vs.

Ta/tt: OR=1.20, 95%CI=1.05-1.37, Pheterogeneity=0.004).

Conclusion: This meta-analysis suggests that the STK15 rs2273535 polymorphism is a candidate gene polymorphism for cancer susceptibility, especially in Asian populations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2013.10.008DOI Listing

Publication Analysis

Top Keywords

rs2273535 polymorphism
16
stk15 rs2273535
12
polymorphism cancer
8
cancer risk
8
stk15
4
polymorphism
4
risk meta-analysis
4
meta-analysis 74896
4
74896 subjects
4
subjects background
4

Similar Publications

Aurora kinase genetic polymorphisms: an association study in Down syndrome and spontaneous abortion.

Hum Cell

May 2022

Laboratório de Genética Humana, Departamento de Biologia Geral, Instituto de Biologia, Universidade Federal Fluminense, Rua Prof. Marcos Waldemar de Freitas Reis-São Domingos, Niterói, RJ, 24210-201, Brazil.

Aneuploidies, such as Down syndrome (DS), are the leading cause of pregnancy loss. Abnormalities in aurora kinase proteins result in genomic instability and aneuploidy, mainly in tumors. Thus, polymorphisms in Aurora kinase genes could influence the occurrence of DS and spontaneous abortion.

View Article and Find Full Text PDF

AURKA gene polymorphisms and central nervous system tumor susceptibility in Chinese children.

Discov Oncol

December 2021

Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Jinsui Road, Guangzhou, 510623, Guangdong, China.

Introduction: Central nervous system (CNS) tumors comprise 15-20% of all malignancies occurring in childhood and adolescence. Previous researches have shown that overexpression and amplification of the AURKA gene could induce multiple human malignancies, with which the connection of CNS tumor susceptibility has not been extensively studied.

Material And Methods: In this study, we assessed whether and to what extent AURKA gene single nucleotide polymorphisms (SNPs) (rs1047972 C > T, rs2273535 T > A, rs8173 G > C) were associated with CNS tumor susceptibility, based on a case-control analysis in 191 CNS tumor patients and 248 controls.

View Article and Find Full Text PDF

The aims of this study were to explore the involvement of Aurora kinase A (AURKA) gene single nucleotide polymorphisms (SNPs) in uterine cervical cancer that has not yet been investigated. One hundred and six patients with cervical invasive cancer and 94 patients with precancerous lesions, and 302 Taiwanese female individuals were included. AURKA SNPs rs2273535, rs6024836, rs2064863 and rs1047972 were analyzed for genotypic distributions using real-time polymerase chain reaction.

View Article and Find Full Text PDF
Article Synopsis
  • Lung adenocarcinoma (LADC) is the most prevalent type of lung cancer, and the study investigates how variations in the Aurora kinase A (AURKA) gene influence the clinical characteristics of patients with different epidermal growth factor receptor (EGFR) phenotypes.
  • The research involved analyzing specific single-nucleotide polymorphisms (SNPs) in AURKA among 105 wild-type EGFR individuals and 167 patients with EGFR mutations, revealing that certain AURKA variants were linked to a lower risk of EGFR mutations, especially in female and nonsmoking patients.
  • Findings indicate that AURKA SNP variants may play a role in the development and progression of L
View Article and Find Full Text PDF

AURKA rs2273535 T>A Polymorphism Associated With Cancer Risk: A Systematic Review With Meta-Analysis.

Front Oncol

June 2020

Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.

Aurora kinase A (AURKA) is a cell cycle regulatory serine/threonine kinase that promotes cell cycle progression. It plays an important role in regulating the transition from G2 to M phase during mitosis. The association between the AURKA rs2273535 T>A polymorphism and cancer risk has been investigated, but the results remain inconsistent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!